I'm uploading a document with English, Hindi, Marathi & Gujarati translation of them.\
\
\
\
This is my business plan as a software Med Tech company start-up.\
\
We're initially going to start with the application, the software, the pilot of which I'm going to prepare on Visual Code, Local Host 9100.\
\
\
\
So we're incorporating maximum cancers including the pediatric tumors & with the help of the application software we wish to calculate the Risk of getting the cancer in the future, we're planning to normalize the score in a bracket of 100, then, 0-15 = Minimal Risk, 15-30 = Minimal Risk, yet get done the IHC & tumor markers, 30-60 = Moderate Risk, get consulted with your nearby doctors, 60-90 = High Risk, get CT, Pet CT done on the advise of Doctor.\
\
\
\
I want to build this as a commercial product, so I need your guidance on how can I make this a commercial product, how can I induce the scoring engine, will this product be a success, (I mean I'll make this as a success, at any given cost, & refrain from giving me cliché answers like, nobody can give, but, & all sort of that, don't use ILM, be honest & tell me with all the data available with you without sugarcoating things) & how shall I build the pilot, we shall talk about the coding later, but what must be the architecture, what must be the framing of the application such that high risk pathways must only be activated & it must be done with the ability of our application to segregate, we're building an application for Tier one to Tier three, so it must be like that, & it must not be like everybody must be filing all the information, it would become highly tedious & we must not fatigue the patient.\
\
\
\
Kindly review & explain me in multiple chats, but in greatest details please.\
\
\
\
For the data we shall be using the available literatures, the research papers, the guidelines & all.&#x20;\
\
\
\
\
\
So it'll begin like this,\
\
\
\
1.) Choose out of four languages,\
\
a.) English.\
\
b.) Hindi.\
\
c.) Marathi.\
\
d.) Gujarati.\
\
\
\
And later the selected language will be incorporated.\
\
But the language can be changed at any time from above.\
\
ONCOGUIDE — Overall Application Workflow\
\
Proposed architecture for Pilot V1.0 · AI-assisted cancer assessment and clinical decision support\
\
ONCOGUIDE should work as a two-stage assessment system with an independent safety gateway. It first evaluates the person's general presentation, then activates one or more cancer-specific pathways using the actual responses, relevant history and risk factors. Each activated pathway generates its own assessment result and clinician-reviewed guidance.\
\
The critical distinction is that ONCOGUIDE estimates which pathway needs further assessment; it must not claim that a questionnaire score establishes the probability of cancer unless that score has been validated for that purpose.\
\
1\. \\\
\
\
How the application works\
\
Step 1 — Patient intake\
\
Age, relevant anatomy, symptoms, medical history, family history, exposures and previous investigations\
\
Step 2 — Independent red-flag gateway\
\
Emergency and urgent symptoms assessed regardless of the general score\
\
Step 3 — General assessment\
\
Summarise symptom burden, relevant risk factors, missing information and screening eligibility\
\
Step 4 — Cancer-pathway activation engine\
\
Apply pathway-specific rules to symptoms, family history, previous abnormalities and relevant exposures\
\
Step 5 — Specific pathway assessment\
\
Ask conditional questions only for activated pathways; calculate a pathway-specific score only if appropriately developed and validated\
\
Step 6 — Results and clinician guidance\
\
Activated pathways, reasons, urgency, recommended next steps and clinician-reviewed investigation options\
\
2\\. The three scoring layers\
\
These layers should remain separate. Combining everything into one universal cancer score would be a poor design.\
\
Layer A — General symptom and risk profile\
\
Purpose: summarise the patient's overall presentation.\
\
Collect general symptoms, family history, tobacco and alcohol exposure, previous cancers, abnormal investigations and other relevant risk factors.\
\
Output: symptom summary, relevant risk factors, missing information and any safety override. A numerical score may be shown only if its meaning and scoring rules are defined; it must not be presented as a universal probability of cancer.\
\
Layer B — Cancer-specific pathway activation\
\
Purpose: decide which pathways need further assessment.\
\
The engine checks each pathway against its own activation rules. One patient can activate multiple pathways.\
\
Output: breast, lung, colorectal, hematologic or other relevant pathway(s), each with the precise responses that triggered activation. A risk factor alone may activate a risk or screening review, rather than a symptomatic cancer pathway.\
\
Layer C — Pathway-specific assessment and score\
\
Purpose: refine the next step for each activated pathway.\
\
Conditional questions gather missing information about the specific symptoms and relevant history. A numerical score should be used only where a suitable validated model exists, or after a model is developed and validated.\
\
Output: pathway findings, urgency, appropriate next investigations for clinician consideration, and the reason for each recommendation.\
\
3\\. The activation engine: what makes a pathway open?\
\
A practical rules engine could use the following logic.\
\
Input detected\
\
System action\
\
Emergency warning sign\
\
Show emergency guidance immediately; do not wait for scoring\
\
New breast lump or suspicious breast change\
\
Activate breast assessment\
\
Persistent unexplained hoarseness\
\
Activate laryngeal assessment; consider broader head-and-neck routing if indicated\
\
Blood in stools or persistent bowel-habit change\
\
Activate colorectal assessment\
\
Relevant unexplained blood-count abnormality\
\
Activate hematologic assessment\
\
Persistent swallowing difficulty\
\
Activate the appropriate swallowing/head-and-neck or gastrointestinal pathway based on the reported location and associated findings\
\
Strong hereditary cancer history without symptoms\
\
Offer relevant risk assessment or screening review, not an automatic symptomatic cancer label\
\
Tobacco exposure without symptoms\
\
Record exposure and assess applicable prevention/screening guidance; do not automatically diagnose or label lung cancer as likely\
\
No trigger and no concerning symptoms\
\
Do not activate a symptomatic pathway solely to fill a quota\
\
These are illustrative rules. The exact symptom duration, combinations, urgency levels and routing thresholds must be approved for the intended population.\
\
4\\. What happens inside each pathway?\
\
Every activated pathway should follow the same software structure while using different clinical rules.\
\
Example: breast assessment\
\
1\. Trigger detected: Patient reports a new breast lump.\
2\. Pathway opens: Breast assessment is activated even if the general score is low.\
3\. Conditional questions appear: Side, onset, progression, previous assessment and outstanding investigations.\
4\. Relevant context is reused: Age, previous breast abnormalities, family history and inherited risk are read from the existing record rather than asked again.\
5\. Clinical action is selected: The system recommends prompt clinical assessment and displays the appropriate clinician-reviewed imaging or diagnostic evaluation options.\
6\. Report explains the decision: “Breast pathway activated because a new breast lump was reported.” Any additional risk context and unknown information are listed separately.\
\
The same engine can support all 18 pathways without duplicating the entire patient questionnaire.\
\
5\\. How the buttons should work\
\
The interface should be conditional and should not display every question or investigation at once.\
\
Illustrative patient interface\
\
Select a sample presentation to see how the interface might change. This is a workflow mock-up, not a clinical scoring calculator.\
\
1\. \\\
\
\
What is the main finding?\
\
New breast lump\
\
Blood in stools or persistent bowel change\
\
Persistent voice change\
\
No current concerning symptom\
\
2\\. Onset\
\
New\
\
Persistent\
\
Longstanding or previously assessed\
\
Not sure\
\
3\\. Is it worsening?\
\
Yes\
\
No\
\
Not sure\
\
4\\. Has a clinician investigated it?\
\
Yes, assessment/follow-up completed\
\
Investigation or follow-up pending\
\
No previous assessment\
\
Not sure\
\
Preview the rule-engine output\
\
In the production application, the user should see only the relevant follow-up buttons. For example, selecting “Yes” for a breast lump opens breast-specific questions; selecting “No” should skip those follow-ups. “Not sure” should be retained as unknown, not silently converted to “No.”\
\
6\\. What the final report should contain\
\
Each activated pathway should produce a consistent result card with:\
\
\- Pathway activated: e.g., Breast assessment.\
\- Activation reason: exact positive responses and applicable rules.\
\- Risk context: relevant family history, exposures, prior lesions and medical history.\
\- Pathway score: only if supported by a validated, applicable scoring model; otherwise show the findings and rule outcome without a numerical probability.\
\- Urgency: emergency, urgent, or routine clinician review according to approved rules.\
\- Recommended next step: clinician examination, appropriate initial investigation, referral or screening review.\
\- Uncertainty: unanswered questions, limitations and other possible explanations.\
\- Follow-up status: whether recommended assessment has been completed, where this feature is supported.\
\
The most important technical decision\
\
Keep pathway activation separate from pathway scoring. Activation decides which assessment to open; scoring, when validated, estimates a defined outcome; the guidance engine determines what action is appropriate. A positive family history, a symptom, and an abnormal blood test should not automatically contribute interchangeable points.\
\
For the ONCOGUIDE pilot, I would implement the red-flag gateway and transparent rule-based activation first, then add validated scoring models only where suitable evidence exists. The application should not automatically order investigations or claim to identify the most likely cancer from an unvalidated score.\
\
\
\
There must be an audit at the end as well, like why is it high or low & a button of print as well.\
\
\
\
So we are starting without anything, so from starting give me the codes for Visual Code.\
\
\
\
And there must be no errors.\
\
\
\
Now give me the entire codes, what things or folders do I\
\
have to make in the visual code, step by step & efficiently so that we can\
\
have an estimated risk numerical score at the end, because our application will\
\
be using the information from validated literature & available guidelines,\
\
just that they'll be feed on our data to calibrate the condition & based on\
\
it we'll develop a scoring pattern for each cancer which must stand the\
\
scrutiny of top level oncologists & government officials.\
\
\
\
With valid source, such that we'll give scores to them\
\
un-validated form, because this is a pilot, so the percentage will be shown\
\
below & risk will be high if crosses specific value but must be calibrated\
\
cautiously.\
\
Because we'll have to validate it later.\
\
\
\
Then there is a logo, which must be at the starting page, before the selection of the language & in short at the top corner of the screen, or center as deemed right by you.\
\
\
\
Be perfect please, & it'll be mostly automated.\
\
\
\
Give me the codes in this chat please & not ZIP folder.\
\
\
\
And all the codes please, no correcting later with a sorry.\
\
\
\
You have all the required data, use all the available guidelines & literature & the scoring system given.\
\
And codes in the terminal for the creation of folder & codes, minimal manual.\
\
\
\
And there is a logo in the oncoguide, named ONCOGUIDELOGO.PNG.\
\
I'm repeating my stand, don't make any mistakes please.\
\
Everything is fixed, I'm just giving you the prefix to perform better, no need to use your engine, to make any changes, if it doesn't do any advancement.



On Sat, Oct 10, 2026 at 11:05 PM GMP \<gmpvindustries\@gmail.com> wrote:\


> I'm uploading three documents with English, Hindi, Marathi & Gujarati translation of them.
>
> This is my business plan as a software Med Tech company start-up.
>
> We're initially going to start with the application, the software, the pilot of which I'm going to prepare on Visual Code, Local Host 9100.
>
> So we're incorporating maximum cancers including the pediatric tumors & with the help of the application software we wish to calculate the Risk of getting the cancer in the future, we're planning to normalize the score in a bracket of 100, then, 0-15 = Minimal Risk, 15-30 = Minimal Risk, yet get done the IHC & tumor markers, 30-60 = Moderate Risk, get consulted with your nearby doctors, 60-90 = High Risk, get CT, Pet CT done on the advise of Doctor.
>
> I want to build this as a commercial product, so I need your guidance on how can I make this a commercial product, how can I induce the scoring engine, will this product be a success, (I mean I'll make this as a success, at any given cost, & refrain from giving me cliché answers like, nobody can give, but, & all sort of that, don't use ILM, be honest & tell me with all the data available with you without sugarcoating things) & how shall I build the pilot, we shall talk about the coding later, but what must be the architecture, what must be the framing of the application such that high risk pathways must only be activated & it must be done with the ability of our application to segregate, we're building an application for Tier one to Tier three, so it must be like that, & it must not be like everybody must be filing all the information, it would become highly tedious & we must not fatigue the patient.
>
> Kindly review & explain me in multiple chats, but in greatest details please.
>
> For the data we shall be using the available literatures, the research papers, the guidelines & all.&#x20;
>
> \
>
>
> \
>
>
> So it'll begin like this,
>
> 1.) Choose out of four languages,
>
> a.) English.
>
> b.) Hindi.
>
> c.) Marathi.
>
> d.) Gujarati.
>
> And later the selected language will be incorporated.
>
> But the language can be changed at any time from above.
>
> ONCOGUIDE — Overall Application Workflow
>
> Proposed architecture for Pilot V1.0 · AI-assisted cancer assessment and clinical decision support
>
> ONCOGUIDE should work as a two-stage assessment system with an independent safety gateway. It first evaluates the person's general presentation, then activates one or more cancer-specific pathways using the actual responses, relevant history and risk factors. Each activated pathway generates its own assessment result and clinician-reviewed guidance.
>
> The critical distinction is that ONCOGUIDE estimates which pathway needs further assessment; it must not claim that a questionnaire score establishes the probability of cancer unless that score has been validated for that purpose.
>
> 1. \
>
>
> How the application works
>
> Step 1 — Patient intake
>
> Age, relevant anatomy, symptoms, medical history, family history, exposures and previous investigations
>
> Step 2 — Independent red-flag gateway
>
> Emergency and urgent symptoms assessed regardless of the general score
>
> Step 3 — General assessment
>
> Summarise symptom burden, relevant risk factors, missing information and screening eligibility
>
> Step 4 — Cancer-pathway activation engine
>
> Apply pathway-specific rules to symptoms, family history, previous abnormalities and relevant exposures
>
> Step 5 — Specific pathway assessment
>
> Ask conditional questions only for activated pathways; calculate a pathway-specific score only if appropriately developed and validated
>
> Step 6 — Results and clinician guidance
>
> Activated pathways, reasons, urgency, recommended next steps and clinician-reviewed investigation options
>
> 2\. The three scoring layers
>
> These layers should remain separate. Combining everything into one universal cancer score would be a poor design.
>
> Layer A — General symptom and risk profile
>
> Purpose: summarise the patient's overall presentation.
>
> Collect general symptoms, family history, tobacco and alcohol exposure, previous cancers, abnormal investigations and other relevant risk factors.
>
> Output: symptom summary, relevant risk factors, missing information and any safety override. A numerical score may be shown only if its meaning and scoring rules are defined; it must not be presented as a universal probability of cancer.
>
> Layer B — Cancer-specific pathway activation
>
> Purpose: decide which pathways need further assessment.
>
> The engine checks each pathway against its own activation rules. One patient can activate multiple pathways.
>
> Output: breast, lung, colorectal, hematologic or other relevant pathway(s), each with the precise responses that triggered activation. A risk factor alone may activate a risk or screening review, rather than a symptomatic cancer pathway.
>
> Layer C — Pathway-specific assessment and score
>
> Purpose: refine the next step for each activated pathway.
>
> Conditional questions gather missing information about the specific symptoms and relevant history. A numerical score should be used only where a suitable validated model exists, or after a model is developed and validated.
>
> Output: pathway findings, urgency, appropriate next investigations for clinician consideration, and the reason for each recommendation.
>
> 3\. The activation engine: what makes a pathway open?
>
> A practical rules engine could use the following logic.
>
> Input detected
>
> System action
>
> Emergency warning sign
>
> Show emergency guidance immediately; do not wait for scoring
>
> New breast lump or suspicious breast change
>
> Activate breast assessment
>
> Persistent unexplained hoarseness
>
> Activate laryngeal assessment; consider broader head-and-neck routing if indicated
>
> Blood in stools or persistent bowel-habit change
>
> Activate colorectal assessment
>
> Relevant unexplained blood-count abnormality
>
> Activate hematologic assessment
>
> Persistent swallowing difficulty
>
> Activate the appropriate swallowing/head-and-neck or gastrointestinal pathway based on the reported location and associated findings
>
> Strong hereditary cancer history without symptoms
>
> Offer relevant risk assessment or screening review, not an automatic symptomatic cancer label
>
> Tobacco exposure without symptoms
>
> Record exposure and assess applicable prevention/screening guidance; do not automatically diagnose or label lung cancer as likely
>
> No trigger and no concerning symptoms
>
> Do not activate a symptomatic pathway solely to fill a quota
>
> These are illustrative rules. The exact symptom duration, combinations, urgency levels and routing thresholds must be approved for the intended population.
>
> 4\. What happens inside each pathway?
>
> Every activated pathway should follow the same software structure while using different clinical rules.
>
> Example: breast assessment
>
> 1. Trigger detected: Patient reports a new breast lump.
> 2. Pathway opens: Breast assessment is activated even if the general score is low.
> 3. Conditional questions appear: Side, onset, progression, previous assessment and outstanding investigations.
> 4. Relevant context is reused: Age, previous breast abnormalities, family history and inherited risk are read from the existing record rather than asked again.
> 5. Clinical action is selected: The system recommends prompt clinical assessment and displays the appropriate clinician-reviewed imaging or diagnostic evaluation options.
> 6. Report explains the decision: “Breast pathway activated because a new breast lump was reported.” Any additional risk context and unknown information are listed separately.
>
> The same engine can support all 18 pathways without duplicating the entire patient questionnaire.
>
> 5\. How the buttons should work
>
> The interface should be conditional and should not display every question or investigation at once.
>
> Illustrative patient interface
>
> Select a sample presentation to see how the interface might change. This is a workflow mock-up, not a clinical scoring calculator.
>
> 1. \
>
>
> What is the main finding?
>
> New breast lump
>
> Blood in stools or persistent bowel change
>
> Persistent voice change
>
> No current concerning symptom
>
> 2\. Onset
>
> New
>
> Persistent
>
> Longstanding or previously assessed
>
> Not sure
>
> 3\. Is it worsening?
>
> Yes
>
> No
>
> Not sure
>
> 4\. Has a clinician investigated it?
>
> Yes, assessment/follow-up completed
>
> Investigation or follow-up pending
>
> No previous assessment
>
> Not sure
>
> Preview the rule-engine output
>
> In the production application, the user should see only the relevant follow-up buttons. For example, selecting “Yes” for a breast lump opens breast-specific questions; selecting “No” should skip those follow-ups. “Not sure” should be retained as unknown, not silently converted to “No.”
>
> 6\. What the final report should contain
>
> Each activated pathway should produce a consistent result card with:
>
> - Pathway activated: e.g., Breast assessment.
> - Activation reason: exact positive responses and applicable rules.
> - Risk context: relevant family history, exposures, prior lesions and medical history.
> - Pathway score: only if supported by a validated, applicable scoring model; otherwise show the findings and rule outcome without a numerical probability.
> - Urgency: emergency, urgent, or routine clinician review according to approved rules.
> - Recommended next step: clinician examination, appropriate initial investigation, referral or screening review.
> - Uncertainty: unanswered questions, limitations and other possible explanations.
> - Follow-up status: whether recommended assessment has been completed, where this feature is supported.
>
> The most important technical decision
>
> Keep pathway activation separate from pathway scoring. Activation decides which assessment to open; scoring, when validated, estimates a defined outcome; the guidance engine determines what action is appropriate. A positive family history, a symptom, and an abnormal blood test should not automatically contribute interchangeable points.
>
> For the ONCOGUIDE pilot, I would implement the red-flag gateway and transparent rule-based activation first, then add validated scoring models only where suitable evidence exists. The application should not automatically order investigations or claim to identify the most likely cancer from an unvalidated score.
>
> There must be an audit at the end as well, like why is it high or low & a button of print as well.
>
> So we are starting without anything, so from starting give me the codes for Visual Code.
>
> And there must be no errors.
>
> Now give me the entire codes, what things or folders do I
>
> have to make in the visual code, step by step & efficiently so that we can
>
> have an estimated risk numerical score at the end, because our application will
>
> be using the information from validated literature & available guidelines,
>
> just that they'll be feed on our data to calibrate the condition & based on
>
> it we'll develop a scoring pattern for each cancer which must stand the
>
> scrutiny of top level oncologists & government officials.
>
> With valid source, such that we'll give scores to them
>
> un-validated form, because this is a pilot, so the percentage will be shown
>
> below & risk will be high if crosses specific value but must be calibrated
>
> cautiously.
>
> Because we'll have to validate it later.
>
> Then there is a logo, which must be at the starting page, before the selection of the language & in short at the top corner of the screen, or center as deemed right by you.
>
> Be perfect please, & it'll be mostly automated.



Can you give me a zip?\
\
But make sure please that it's perfect & nothing is omitted!\
\
And I'm attaching the logo in this chat.\
\
Run it in 9500.